BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Ignite II - ECPv6.15.18//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Ignite II
X-ORIGINAL-URL:https://gmkb.org
X-WR-CALDESC:Events for Ignite II
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:America/New_York
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20230312T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20231105T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20240310T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20241103T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20250309T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20251102T060000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20240229T090000
DTEND;TZID=America/New_York:20240229T100000
DTSTAMP:20260416T040912
CREATED:20231106T001846Z
LAST-MODIFIED:20240226T010923Z
UID:3593-1709197200-1709200800@gmkb.org
SUMMARY:Translating Science from Bench to Bedside: A Case for Extracellular Vesicles
DESCRIPTION:Translating Science from Bench to Bedside: A Case for Extracellular Vesicles \nThursday\, February 29 | 9 a.m. ET | Online \nSpeaker: Dr. Carlos Salomon Gallo \nDr. Salomon is the head of the Translational Extracellular Vesicles in Obstetrics and Gynae-Oncology Group\, NHMRC Investigator Fellow and is considered a worldwide authority on extracellular vesicles (EVs) biomarkers for complications of pregnancies and ovarian cancer (OC). In the last 10 years\, Dr. Salomon’s primary research and commercialization activities have focused on the identification and validation of biomarkers\, and development of In Vitro Multivariate Index Assays for clinically relevant complications (including ovarian cancers\, and obstetrical syndromes) and their translation into clinical applications. He is a pioneer in investigating the release of EVs by the placenta and tumor cells and their utility as a biomarker for a wide range of pregnancy complications and OC. \nThis talk will cover the burgeoning field of EVs signaling holds the potential to revolutionize our understanding of cancer biology and offers new avenues for non-invasive diagnostics and therapeutic interventions. EVs have been implicated in various aspects of cancer progression\, including tumor initiation\, metastasis\, and response to therapy. From the early stages of tumor development\, tumor-derived EVs are detectable in the circulation. \nTo learn more and register\, visit the GGMC Educational Webinar Series webpage. \nPlease note: Registration is required for this webinar. \n 
URL:https://gmkb.org/event/translating-science-from-bench-to-bedside-a-case-for-extracellular-vesicles/
LOCATION:Virtual
END:VEVENT
END:VCALENDAR